Media Advisory - Neo Performance Materials Inc. Second Quarter 2025 Earnings Release & Webcast
Media Advisory - Neo Performance Materials Inc. Second Quarter 2025 Earnings Release & Webcast |
[22-July-2025] |
TORONTO, July 22, 2025 /CNW/ - Neo Performance Materials Inc. ("Neo" or the "Company") (TSX: NEO) (OTCQX: NOPMF) will report its second-quarter results for the period ended June 30, 2025, before the Toronto market opens on Tuesday, August 12, 2025. Teleconference Details Date: Tuesday, August 12, 2025 Time: 10:00 AM ET | 7:00 AM PT Webcast: LINK Conference call: 1-416-945-7677 (local) or 1-888-699-1199 (toll-free long distance) or by visiting Dial-in Link. A replay of the webcast will be available by clicking on the webcast LINK above and will be archived on the Company's website for a limited period. A teleconference recording may be accessed by calling 1-289-819-1450 (local) or 1-888-660-6345 (toll-free long distance) and entering passcode 04579# until September 12, 2025. About Neo Performance Materials Neo manufactures the building blocks of many modern technologies that enhance efficiency and sustainability. Neo's advanced industrial materials – magnetic powders, rare earth magnets, magnetic assemblies, specialty chemicals, metals, and alloys – are critical to the performance of many everyday products and emerging technologies. Neo's products fast-forward technologies for the net-zero transition. The business of Neo is organized along three segments: Magnequench, Chemicals & Oxides and Rare Metals. Neo is headquartered in Toronto, Ontario, Canada; with corporate offices in Greenwood Village, Colorado, United States; Singapore; and Beijing, China. Neo has a global platform that includes manufacturing facilities located in China, Germany, Canada, Estonia, Thailand and the United Kingdom, as well as a dedicated research and development center in Singapore. For more information, please visit www.neomaterials.com. SOURCE Neo Performance Materials, Inc. | ||
Company Codes: Toronto:NEO, OTC-BB:NOPMF, OTC-PINK:NOPMF, OTC-QX:NOPMF |